跳至主要内容
临床试验/ISRCTN76463647
ISRCTN76463647已完成不适用

Optimising thromboembolic and stroke prevention: a randomised controlled trial of pharmacist-managed oral anticoagulotherapy

Cité de la Santé de Laval (Canada)0 个研究点目标入组 500 人开始时间: 2005年9月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. The patient is referred to the Pharmacy Managed Anticoagulation Service (PMAS) with a prescription of warfarin for at least six months
  • 2. The patient is aged 18 years and older, either sex
  • 3. The patient agrees to go to the Cité de la Santé de Laval, the Centre Hospitalier Ambulatoire Régional de Laval, or one of the four Laval Centre Local de Services Communautaire for blood drawing during participation in the study (six months)
  • 4. The patient lives in the Laval area
  • 5. The patient is able to read and speak French or English
  • 6. The patient agrees to participate in the study and has signed the informed consent form
  • 7. The patient's treating physician has agreed to participate and has signed the informed consent form
  • 8. It is expected that the patient will be transferred to the treating physician

排除标准

  • 1. The patient participates to another study
  • 2. The patient is referred to the PMAS for a pre-admission

研究者

发起方
Cité de la Santé de Laval (Canada)

相似试验